X
Record #72235

Targeting transforming growth factor beta (TGF-β) using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer

Original paper date
Sep 1, 2023
Institution
Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran · Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran · Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran · Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran · Department of Pharmacology, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran · Division of Medical Education, Brighton and Sussex Medical School, Falmer, Brighton, BN1 9PH, Sussex, UK · Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran · Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran · Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran · College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq · School of Mechanical, Medical and Process Engineering, Queensland University of Technology, 2 George Street, Brisbane, QLD, 4000, Australia · Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia
Open access
No
Article type
Research Article
Broad categories
(BLS) Genetics(HSC) Medicine - Oncology(HSC) Medicine - Pharmacology
Citation lifecycle

How this paper is being cited

Pre-retraction
21
Same day
0
Post-retraction
0
% post-retraction
0.0%
~8.8 citations/yr before retraction · ~0.0 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse